Equities

Affluent Medical SAS

Affluent Medical SAS

Actions
Health CareMedical Equipment and Services
  • Price (EUR)1.85
  • Today's Change0.04 / 2.22%
  • Shares traded670.00
  • 1 Year change+47.60%
  • Beta0.2731
Data delayed at least 15 minutes, as of Nov 08 2024 14:39 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Affluent Medical SAS is a France-based company that manufactures surgical implants. It designs minimally invasive prostheses at mimicking human anatomy and restoring native physiology for critical functions in cardiovascular and urological therapies. It provides several products such as Kalios, Epygon, Artus. It helps in treating heart disease and urinary incontinence. The Company provides transcatheter and flow control technologies, such as mimicry of anatomy and restoration of physiology minimally invasive implant procedures, optimized and biocompatible components.

  • Revenue in EUR (TTM)0.00
  • Net income in EUR-17.04m
  • Incorporated2018
  • Employees66.00
  • Location
    Affluent Medical SAS320 avenue ArchimedeLes pleiades III Batiment BAIX-EN-PROVENCE 13100FranceFRA
  • Phone+33 442951220
  • Websitehttps://www.affluentmedical.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Gentian Diagnostics ASA12.46m188.30k53.63m58.00324.803.9255.744.300.12620.12629.3510.470.77921.698.402,533,190.001.18-10.761.33-11.8651.6941.461.51-26.995.01--0.0394--32.9827.6354.92---4.92--
Omda AS35.40m7.68m54.97m295.007.1311.124.241.554.354.3520.602.790.5886238.3610.381,434,162.0013.80-4.9218.03-6.3792.8990.2223.45-9.831.142.560.8946--12.3019.83179.30---3.93--
Mentice AB24.21m-879.89k56.89m134.00--4.3239.892.35-0.3998-0.399810.955.970.90463.053.282,301,221.00-3.29-7.69-6.32-13.0785.3683.67-3.63-10.001.00--0.0382--25.5411.7490.81---10.83--
Carmat SA5.53m-53.35m57.41m162.00------10.38-1.76-1.760.1787-0.64190.09321.611.2830,379.12-89.92-76.92-113.71-94.38-535.50---964.91-4,636.641.69-17.371.63--710.72---0.3502--16.99--
Senzime AB (publ)4.77m-11.34m62.36m52.00--2.68--13.08-1.09-1.090.45952.380.15331.574.91---36.44-35.69-39.12-38.0033.27-20.59-237.75-558.682.62--0.0739--154.7761.90-1.09---3.69--
Oncosem Onkolojik Sistemlr Sny v Tcrt AS8.44m-3.63m62.54m249.00--9.84--7.41-5.70-5.7013.129.811.023.664.56959,448.30-43.70---61.60--21.29---43.01--1.10-5.210.2552---17.90---284.37------
ADDvise Group AB (publ)140.25m9.87m71.21m643.0020.223.053.920.50770.59350.59358.383.930.5658.375.772,606,250.003.983.724.824.7742.0748.957.045.891.402.350.69690.940544.3038.6227.62--30.35--
Fonet Bilgi Teknolojileri AS10.66m5.13m71.29m498.006.082.888.286.693.003.003.326.320.5937375.463.92898,996.6028.5515.8532.4418.1627.2435.8448.1036.801.72--0.00620.005.3647.56520.6464.7949.71--
Affluent Medical SAS0.00-17.04m72.58m66.00--2.35-----0.5338-0.53380.000.78640.00----0.00-28.43---34.69-------------24.620.3586-------2.80------
Inspecs Group PLC235.28m-4.95m75.39m1.67k--0.61347.350.3204-0.0404-0.04041.921.000.86672.317.65116,640.80-1.82-1.48-2.62-2.1551.4648.50-2.10-1.970.86960.64410.377--1.1636.4584.22--51.04--
Median Technologies SA21.84m-25.35m75.92m250.00------3.48-1.29-1.291.11-1.190.7873-30.313.5790,227.27-91.41-54.57---157.51105.00101.57-116.10-93.700.6879-138.584.77---6.1028.52-13.70--38.38--
SDI Group PLC79.39m5.10m78.78m503.0015.551.447.930.99240.04020.04020.62560.43440.7930.9895.34130,906.605.127.856.1110.0130.8464.066.469.481.354.850.3210.00-2.5630.469.3017.2212.08--
C Rad AB42.86m4.61m81.01m94.0018.043.1815.011.891.581.5814.728.961.235.042.725,712,816.0013.255.0919.167.0246.3043.1210.814.862.32--0.00490.0040.9217.44375.0510.8933.69--
Optomed Oyj14.71m-4.85m85.98m110.00--3.14--5.85-0.2761-0.27610.85011.400.47621.694.10129,035.10-15.71-12.95-19.11-15.9067.7765.69-32.98-27.842.67--0.1424--3.003.4718.84--7.26--
Creo Medical Group PLC36.53m-27.01m89.45m278.00--1.37--2.45-0.0629-0.06290.08520.13110.38351.853.33105,574.90-28.35-26.07-32.89-30.9449.5047.58-73.93-118.242.38--0.2305--13.36--19.44------
Data as of Nov 08 2024. Currency figures normalised to Affluent Medical SAS's reporting currency: Euro EUR

Institutional shareholders

0.14%Per cent of shares held by top holders
HolderShares% Held
Friedland Gestion SASas of 28 Jun 202455.23k0.14%
Data from 28 Jun 2024 - 28 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.